Vitiligo Complicating chronic Hepatitis B patients treated with α-Interferon (Report of two cases)
Authors
Abstract:
α-Interferon is an antiviral agent used in treatment of chronic hepatitis B. Triggering of the underlying autoimmune disease or exacerbation of pre-existing auto immune disease is documented with α-interferon, but there are few reports about occurrence of autoimmune disorders such as systemic lupus erythematosus, Vitiligo, hypo and hyperthyroidism after administration of α-interferon in the literature. We report here in two cases of chronic hepatitis B treated with a-interferon, who developed Vitiliginous lesions. These lesions disappeared within 3 to 6 months after discontinuing α-interferon therapy. Until now, the occurrence of vitiligo after administration of α-interferon in chronic hepatitis B has not been reported.
similar resources
rosuvastatin reduces nonalcoholic fatty liver disease in patients with chronic hepatitis c treated with α-interferon and ribavirin
full text
Effect of Interferon-α and Combined Interferon-α with Lamivudine Treatment on Anthropometric Measurements in Children with Chronic Hepatitis B.
ated in each group, TST and SST Z-scores of HBeAg-positive patients were significantly higher than those in anti-HBe positive patients in group 1 ( p < 0.05). No statistically significant differences were observed in the other Z-scores ( p > 0.05). When HBeAg-positive patients and antiHBe-positive patients were compared in group 2, TST, SST, MAC, and MAMA Z-scores were not found to be statistic...
full textTreatment of Chronic Hepatitis B with Tenofovir
Background:Tenofovir is among the first-line treatments for chronic hepatitis B (CHB) virus infection. We evaluated the efficacy of Tenofovir in the treatment of Iranian adult patients with CHB. Methods: In a retrospective study, we evaluated 154 HBsAg positive patients referred to Sadoughi hospital in Yazd-Iran for treatment ...
full textAdd-on Pegylated Interferon Alpha-2a Therapy in Chronic Hepatitis B Japanese Patients Treated with Entecavir
Entecavir requires long-term administration. Pegylated interferon (PEG-IFN) therapy leads to significant reduction of hepatitis B surface antigen (HBs Ag) levels. This study aimed to assess the safety and efficacy of adding PEG-IFN-α-2a to entecavir toward cessation of entecavir. A total of 23 patients treated with entecavir underwent add-on PEG-IFN-α-2a therapy (90 μg per week) for 48 weeks. V...
full textSerous Retinal Detachments Complicating Interferon-α and Ribavirin Treatment in Patients with Hepatitis C
PURPOSE To report the cases of two patients with chronic hepatitis C infection showing serous retinal detachments similar to Vogt-Koyanagi-Harada (VKH) disease. METHODS We reviewed the clinical records of two patients who were diagnosed with VKH-like disease during combined interferon-α (IFNα) and ribavirin treatment. RESULTS Interruption of IFNα and ribavirin treatment in association with ...
full textThe Study of Cerumen Hepatitis B Infection in Chronic Hepatitis B Patients by Real-Time PCR
Introduction: The hepatitis B is a viral infection that causes a big problem globally. About 2 billion people worldwide are infected and there are now about 400 million HBV-DNA carriers around the world. HBV infection is the ninth cause of death worldwide and infects about 350 million new cases each year in the world. HBV-DNA can be spotted in different body secretions and fluids, including se...
full textMy Resources
Journal title
volume 5 issue 3
pages 45- 49
publication date 2002-04-01
By following a journal you will be notified via email when a new issue of this journal is published.
Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023